Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-04-23-Speech-1-118"

PredicateValue (sorted: default)
dcterms:Is Part Of
lpv:document identification number
lpv:translated text
"Every time we begin talking about advanced therapy medicinal products, stem cell or embryonic cell therapies, or embryo research or organ transplantation, vehement debate inevitably ensues. Our points of view differ widely, regardless of age, sex, nationality or political convictions, a sure sign of the complexity of the question. It is no small undertaking to have decided to draw up a piece of legislation that seeks to provide a unified regulation of this border area between ethics and science. For these therapies and medicines increasingly represent life and death. By using, or by not using them, either way we are making decisions about human lives. Advanced therapy means life for many thousands of European citizens. It is the last ray of hope offering the prospect of a healthier, fuller life. In the developing world, however, it can mean death, since the illegal trade in organs is already causing the maiming and death of thousands of people. At the same time, our goal cannot be to stop the development of technology. What can, however, be our goal is to find answers to the moral and ethical questions raised by technical advances. We need the current legislation to point the way, to help ensure that technical development means an affirmation of life. This is not a question of the struggle between good and evil, but of what is technically possible and yet ethically permissible. I owe Mr Mikolašik and my other colleagues gratitude for the fine compromise they have prepared, and trust that the legislation to be brought into effect by our votes will be on the side of life."@en1

Named graphs describing this resource:


The resource appears as object in 2 triples

Context graph